Ohr Pharmaceutical to Present at the 11th Annual BIO Investor Forum

NEW YORK, Oct. 5, 2012 /PRNewswire/ — Ohr Pharmaceutical (OHRP), a pharmaceutical company focused on the development of novel therapeutics for large unmet medical needs, announced today that Dr. Irach Taraporewala, Chief Executive Officer of …

Share